Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems

Published on Sep 16, 2016in Science41.04
· DOI :10.1126/science.aaf8729
Keiji Nishida23
Estimated H-index: 23
(Kobe University),
Takayuki Arazoe6
Estimated H-index: 6
(Kobe University)
+ 9 AuthorsAkihiko Kondo68
Estimated H-index: 68
(Kobe University)
INTRODUCTION To combat invading pathogens, cells develop an adaptive immune response by changing their own genetic information. In vertebrates, the generation of genetic variation (somatic hypermutation) is an essential process for diversification and affinity maturation of antibodies that function to detect and sequester various foreign biomolecules. The activation-induced cytidine deaminase (AID) carries out hypermutation by modifying deoxycytidine bases in the variable region of the immunoglobulin locus that produces antibody. AID-generated deoxyuridine in DNA is mutagenic as it can be miss-recognized as deoxythymine, resulting in C to T mutations. CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) is a prokaryotic adaptive immune system that records and degrades invasive foreign DNA or RNA. The CRISPR/Cas system cleaves and incorporates foreign DNA/RNA segments into the genomic region called the CRISPR array. The CRISPR array is transcribed to produce crispr-RNA that serves as guide RNA (gRNA) for recognition of the complementary foreign DNA/RNA in a ribonucleoprotein complex with Cas proteins, which degrade the target. The CRISPR/Cas system has been repurposed as a powerful genome editing tool, because it can be programmed to cleave specific DNA sequence by providing custom gRNAs. RATIONALE Although the precise mechanism by which AID specifically mutates the immunoglobulin locus remains elusive, targeting of AID activity is facilitated by the formation of a single-stranded DNA region, such as a transcriptional RNA/DNA hybrid (R-loop). The CRISPR/Cas system can be engineered to be nuclease-inactive. The nuclease-inactive form is capable of unfolding the DNA double strand in a protospacer adjacent motif (PAM) sequence-dependent manner so that the gRNA binds to complementary target DNA strand and forms an R-loop. The nuclease-deficient CRISPR/Cas system may serve as a suitable DNA-targeting module for AID to catalyze site-specific mutagenesis. RESULTS To determine whether AID activity can be specifically targeted by the CRISPR/Cas system, we combined dCas9 (a nuclease-deficient mutant of Cas9) from Streptococcus pyogenes and an AID ortholog, PmCDA1 from sea lamprey, to form a synthetic complex (Target-AID) by either engineering a fusion between the two proteins or attaching a SH3 (Src 3 homology) domain to the C terminus of dCas9 and a SHL (SH3 interaction ligand) to the C terminus of PmCDA1. Both of these complexes performed highly efficient site-directed mutagenesis. The mutational spectrum was analyzed in yeast and demonstrated that point mutations were dominantly induced at cytosines within the range of three to five bases surrounding the –18 position upstream of the PAM sequence on the noncomplementary strand to gRNA. The toxicity associated with the nuclease-based CRISPR/Cas9 system was greatly reduced in the Target-AID complexes. Combination of PmCDA1 with the nickase Cas9(D10A) mutant, which retains cleavage activity for noncomplementary single-stranded DNA, was more efficient in yeast but also induced deletions as well as point mutations in mammalian cells. Addition of the uracil DNA glycosylase inhibitor protein, which blocks the initial step of the uracil base excision repair pathway, suppressed collateral deletions and further improved targeting efficiency. Potential off-target effects were assessed by whole-genome sequencing of yeast as well as deep sequencing of mammalian cells for regions that contain mismatched target sequences. These results showed that off-target effects were comparable to those of conventional CRISPR/Cas systems, with a reduced risk of indel formation. CONCLUSION By expanding the genome editing potential of the CRISPR/Cas9 system by deaminase-mediated hypermutation, Target-AID demonstrated a very narrow range of targeted nucleotide substitution without the use of template DNA. Nickase Cas9 and uracil DNA glycosylase inhibitor protein can be used to boost the targeting efficiency. The reduced cytotoxicity will be beneficial for use in cells that are sensitive to artificial nucleases. Use of other types of nucleotide-modifying enzymes and/or other CRISPR-related systems with different PAM requirements will expand our genome-editing repertoire and capacity.
  • References (27)
  • Citations (245)
#1Binyamin A. Knisbacher (BIU: Bar-Ilan University)H-Index: 7
#2Doron Gerber (BIU: Bar-Ilan University)H-Index: 21
Last.Erez Y. Levanon (BIU: Bar-Ilan University)H-Index: 32
view all 3 authors...
#1Ian SlaymakerH-Index: 9
#2Linyi Gao (MIT: Massachusetts Institute of Technology)H-Index: 6
Last.Feng ZhangH-Index: 104
view all 6 authors...
#1Manuel Stemmer (Heidelberg University)H-Index: 3
#2Thomas Thumberger (Heidelberg University)H-Index: 10
Last.Juan L. Mateo (Heidelberg University)H-Index: 9
view all 5 authors...
#1Shengdar Q. Tsai (Harvard University)H-Index: 24
#2Zongli Zheng (KI: Karolinska Institutet)H-Index: 24
Last.Long P. Le (Harvard University)H-Index: 19
view all 12 authors...
#1Patrick Hsu (Broad Institute)H-Index: 15
#2Eric S. Lander (Broad Institute)H-Index: 245
Last.Feng Zhang (Broad Institute)H-Index: 104
view all 3 authors...
Cited By245
#1Tian-Lin Cheng (CAS: Chinese Academy of Sciences)H-Index: 7
#2Shuo Li (Fudan University)
Last.Zilong Qiu (CAS: Chinese Academy of Sciences)H-Index: 23
view all 0 authors...
#1Zheng Lin Tan (THU: Tsinghua University)
#2Xiang Zheng (THU: Tsinghua University)H-Index: 3
Last.Chong Zhang (THU: Tsinghua University)H-Index: 23
view all 6 authors...
#1Junjie Tan (MPG: Max Planck Society)H-Index: 1
#2Fei Zhang (MPG: Max Planck Society)H-Index: 1
Last.Ralph Bock (MPG: Max Planck Society)H-Index: 62
view all 4 authors...
#1Alba Carreras (Sahlgrenska University Hospital)H-Index: 2
#2Alba Carreras (Sahlgrenska University Hospital)H-Index: 1
Last.Mikael BjursellH-Index: 19
view all 20 authors...
#1Jingke XieH-Index: 3
#2Weikai GeH-Index: 2
Last.Yu Zhao (CAS: Chinese Academy of Sciences)H-Index: 18
view all 23 authors...
#1Wakako Kumita (Central Institute for Experimental Animals)H-Index: 2
#2Kenya Sato (Central Institute for Experimental Animals)H-Index: 3
Last.Yasubumi Sakakibara (Keio: Keio University)H-Index: 29
view all 13 authors...
#1Jina Yang (SNU: Seoul National University)H-Index: 7
#2Beomhee Kim (SNU: Seoul National University)
Last.Sang Woo Seo (SNU: Seoul National University)H-Index: 17
view all 5 authors...
View next paperRNA-Guided Human Genome Engineering via Cas9